Ro and Novo Announce Research Collaboration to Generate First-of-its-Kind Real-World Evidence on the Wegovy® Pill

PartnershipWegovyGLP-1Positive

AI Analysis

Summary

Ro and Novo Nordisk announced a research collaboration to generate real-world evidence on the Wegovy pill, with initial findings presented at EASD2026 showing outcomes from patients who switched from injectable GLP-1 to the oral formulation.

Outcome Details

Research collaboration announced to generate real-world evidence on Wegovy pill; debut research presented at EASD2026 conference

Importance:5/10

Sentiment:

0.50

partnershipresearch collaborationreal-world evidenceWegovyGLP-1direct-to-patientconference presentation

Related Companies

$NVO

Read the original article

Published by PR Newswire Biotech on September 30, 2026 9:45 AM

Read Original